Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01HUQ
|
|||
| Former ID |
DNC014585
|
|||
| Drug Name |
3-(1H-Pyrrol-3-yl)-propionamide
|
|||
| Synonyms |
1H-Pyrrole-3-propanamide; CHEMBL277776; 152509-75-6; 3-(1H-Pyrrol-3-yl)-propionamide; ACMC-20n6gu; CTK0I3006; DTXSID90435928; BDBM50287316
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H10N2O
|
|||
| Canonical SMILES |
C1=CNC=C1CCC(=O)N
|
|||
| InChI |
1S/C7H10N2O/c8-7(10)2-1-6-3-4-9-5-6/h3-5,9H,1-2H2,(H2,8,10)
|
|||
| InChIKey |
TWGRVIPCCGRSNM-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 152509-75-6
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Protein processing in endoplasmic reticulum | |||
| Apoptosis | ||||
| Alzheimer's disease | ||||
| Reactome | Degradation of the extracellular matrix | |||
| WikiPathways | Focal Adhesion | |||
| Integrated Pancreatic Cancer Pathway | ||||
| Alzheimers Disease | ||||
| Integrin-mediated Cell Adhesion | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of cystamidin a (pyrrole-3-propanamide), a reported calpain inhibitor, Bioorg. Med. Chem. Lett. 6(13):1541-1542 (1996). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.